Table 1.
Demographic and clinical characteristics of the studied groups (MM, RRMM, Ps, HVs).
| Characteristics | MM (N = 59) | RRMM (N = 17) | Ps (N = 80) | HVs (N = 23) |
|---|---|---|---|---|
| Age (years), median (range) | 68 (41–84) | 59 (47–82) | 47 (18–77) | 28 (18–58) |
| Sex | ||||
| Female, n | 26 | 12 | 14 | 10 |
| Male, n | 33 | 5 | 66 | 13 |
| ISS disease stage, n (%) | n/a | n/a | n/a | |
| I | 21 (38.9) | |||
| II | 15 (27.8) | |||
| III | 18 (33.3) | |||
| 5 n/a | ||||
| PASI, median (range) | n/a | n/a | 12.05 (2.7–49.4) | n/a |
n/a, not applicable; MM, multiple myeloma; Ps, psoriasis; RRMM, relapsed/refractory multiple myeloma; HVs, healthy volunteers; ISS, the International Staging System; PASI, Psoriasis Area and Severity Index.